Insider Transactions in Q1 2022 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,455
-22.34%
|
$803,225
$95.05 P/Share
|
|
Mar 18
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
300
-0.79%
|
$28,500
$95.0 P/Share
|
|
Feb 08
2022
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
980
-4.63%
|
$77,420
$79.65 P/Share
|
|
Feb 08
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
980
-4.6%
|
$77,420
$79.67 P/Share
|
|
Feb 08
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
700
-3.87%
|
$55,300
$79.56 P/Share
|
|
Feb 08
2022
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
980
-0.87%
|
$77,420
$79.67 P/Share
|
|
Feb 08
2022
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,274
-0.49%
|
$179,646
$79.49 P/Share
|
|
Feb 08
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
911
-2.33%
|
$71,969
$79.51 P/Share
|
|
Feb 08
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
701
-3.61%
|
$55,379
$79.53 P/Share
|
|
Feb 08
2022
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
980
-3.83%
|
$77,420
$79.52 P/Share
|
|
Feb 08
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
700
-19.34%
|
$55,300
$79.62 P/Share
|
|
Feb 07
2022
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,310
-8.13%
|
$264,800
$80.79 P/Share
|
|
Feb 07
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,119
-6.94%
|
$329,520
$80.76 P/Share
|
|
Feb 07
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,158
-4.26%
|
$172,640
$80.64 P/Share
|
|
Feb 07
2022
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
5,900
-1.34%
|
$472,000
$80.76 P/Share
|
|
Feb 07
2022
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,710
-0.63%
|
$696,800
$80.82 P/Share
|
|
Feb 07
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,168
-2.81%
|
$253,440
$80.69 P/Share
|
|
Feb 07
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
2,681
-4.91%
|
$214,480
$80.72 P/Share
|
|
Feb 07
2022
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,744
-5.58%
|
$219,520
$80.79 P/Share
|
|
Feb 07
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
240
-9.48%
|
$19,440
$81.07 P/Share
|
|
Jan 24
2022
|
Stephen A Sherwin Director |
SELL
Open market or private sale
|
Direct |
15,000
-37.45%
|
$1,110,000
$74.43 P/Share
|
|
Jan 24
2022
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.25%
|
$90,000
$6.66 P/Share
|
|
Jan 10
2022
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,632
-11.01%
|
$194,768
$74.5 P/Share
|
|
Jan 05
2022
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
28,266
-21.21%
|
$2,402,610
$85.5 P/Share
|
|
Jan 05
2022
|
Kyle Gano Chief Business Development Off |
BUY
Exercise of conversion of derivative security
|
Direct |
28,266
+17.5%
|
$226,128
$8.66 P/Share
|